{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 12,
        "end": 18
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 32,
        "end": 38
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 55,
        "end": 61
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 78,
        "end": 84
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 104,
        "end": 108
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 173,
        "end": 182
      }
    },
    {
      "id": "T13",
      "obj": "Chemical",
      "span": {
        "begin": 313,
        "end": 321
      }
    },
    {
      "id": "T17",
      "obj": "Chemical",
      "span": {
        "begin": 127,
        "end": 135
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25594941_4",
  "text": "rs9923231 ( VKORC1 ) , rs7294 ( VKORC1 ) , rs1057910 ( CYP2C9 ) , rs2108622 ( CYP4F2 ) , and rs699664 ( GGCX ) involved in the warfarin action mechanism and the circulatory vitamin K were selected to investigate their polymorphism characteristics and their effects on the pharmacodynamics and pharmacokinetics of warfarin in Chinese population ."
}
